Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1.22	40.85	40.36
Graham Fair Price	6.47	249.82	234.63
PEG	-94.09	0.85	-14.39
Price/Book	-0.02	1.94	1.94
Price/Cash Flow	300.76	-163.13	40.71
Prices/Earnings	-11.77	12.24	13.87
Price/Sales	-1.13	16.29	16.47
Price/FCF	300.76	-163.13	40.71
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-6.89	0.46	0.50
Operating Margin	4.62	0.36	0.34
ROA	13.68	0.01	0.01
ROE	0.03	0.04	13.31
ROIC	0.02	0.03	14.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.20	< 0.005	4959.05
Dividends QOQ	< 0.005	0.06	1547.90
EBIT QOQ	0.04	0.07	76.24
EPS QOQ	< 0.005	0.14	1392.16
FCF QOQ	0.25	-1.25	398.75
Revenue QOQ	0.07	0.02	-71.78
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-7.59	-7.28	4.12
Days Sales Outstanding (DSO)	76.10	75.40	-0.93
Inventory Turnover	-11.85	-12.36	-4.29
Debt/Capitalization	0.22	0.23	5.17
Quick Ratio	11.71	10.39	-11.26
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	264.61	264.66	0.02
Cash	71.33	73.67	3.27
Capex	-0.83	-0.43	48.87
Free Cash Flow	12.60	-3.14	-75.05
Revenue	31.14	31.50	1.15
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	15.46	13.22	-14.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.50	1.16	130.61
Naive Interpretation	Member

06 - Financial Health · Bad

Rating